At a glance
ClinicalIndex Comparison RecordN/ACompleted· 92 enrolled
Drug / intervention
Genotype Detectiongenetic
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Study Based on Genetic Polymorphisms Related to Individual Variations of Side Effects of Cyclophosphamide in Systemic Lupus Erythematosus Treatment
In Brief
A clinical study evaluating Genotype Detection for Systemic Lupus Erythematosus. Completed, enrolled 92 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the genotype-based personal prescription of cyclophosphamide with the traditional prescription.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSystemic Lupus Erythematosus
CountriesChina
CollaboratorsFirst Affiliated Hospital, Sun Yat-Sen University
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 2012
Enrollment StartOct 2012
Primary CompletionDec 2013
Study CompletionMar 2014
TodayJul 2026
First PostedSep 21, 2012
Enrollment StartOct 1, 2012
Primary CompletionDec 1, 2013
Study CompletionMar 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 13.8 years ago
Interventions
Genotype Detectiongenetic
To Genotype cases in the experimental group and divide them into three groups, including extensive metaboliser (EM), intermediate metaboliser (IM) and poor metaboliser (PM).